Normal View Dyslexic View
Impact of portable normothermic blood-based machine perfusion on outcomes of liver transplant. The OCS Liver PROTECT randomized clinical trial.
2 May 2022
Randomized clinical trials Transplantation
Markmann JF, Aboulijoud MS, Ghobrial RM, Bhati CS, Pelletier SJ, Lu AD et al .
JAMA Surg 2022;
Of 293 patients included, machine perfusion reduced the rate of early graft dysfunction (18 versus 31 per cent, P=0.01), and improved use of the liver from donors after cardiac death (51 versus 26 per cent, P=0.007).
Published on: 2 May 2022
Article ID: rct224
Thank you to our strategic partners
.png)
.jpg){kind=logo}
Connect
